The Jakarta Post
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultspharmaceutical-industry
Companies 1 year ago
PREMIUM
Indian firms eye investment in Indonesia’s pharma sector, ambassador says
Indian Ambassador to Indonesia Sandeep Chakravorty says at least three Indian pharmaceutical companies are eyeing investment opportunities in Indonesia, including MSN Laboratories and Dr. Reddy’s Laboratories.
Companies 2 years ago
PREMIUM
Kimia Farma to halve production facility amid financial woes
Indonesia’s biggest pharmaceutical company plans to close five factories within the next two or three years in a measure that its director of production and supply chain attributed to the need to ensure sustainability.
Society 2 years ago
PREMIUM
Australia’s Recce, Etana team up to develop synthetic antibiotics in Indonesia
The private sector agreement aims to develop a new class of synthetic antibiotics to address the growing issue of drug-resistant superbugs, which can cause previously treatable infectious diseases to become deadly.
Society 3 years ago
Jakarta court hears class-action suit for tainted cough syrup
About 200 children have died of acute kidney injury in Indonesia since last year and authorities have said two ingredients, ethylene glycol and diethyelene glycol, found in some syrup-based paracetamol medications are linked to the illness.
Society 3 years ago
PREMIUM
Two more drug companies have medicinal syrup licenses revoked
The Food and Drug Monitoring Agency (BPOM) revoked two more pharmaceutical companies’ licenses to produce medicinal syrups on Wednesday, bringing to five the total number of firms sanctioned for the manufacture of toxic medicines linked to deadly cases of acute kidney injury (AKI).
Society 3 years ago
PREMIUM
BPOM: Cost-cutting by pharma firms to blame for AKI spike
The Food and Drug Monitoring Agency (BPOM) has alleged that cost-cutting measures by drug manufacturers are to blame for toxic medicines that have caused a recent spike in acute kidney injury (AKI) cases, which has left dozens of children dead this year.
Editor's Picks
Popular
- Mass poisonings cast doubt on free meals reforms
- New data rules could unlock cross-border data flows
- Malaysia must not breathe Indonesia’s governance failure
- Volcanic eruptions take toll on economy
- Search intensifies for journalists, crew as Anak Krakatau ashfall eases
- Mitigation budget under scrutiny as Indonesia grapples with disasters
- Indonesian wildfire emissions surge to world's highest
- Anak Krakatau doesn't need an earthquake to kill
- Student suffers memory loss, seizures after free meal food poisoning
- Search resumes for missing journalists on Anak Krakatau mission
